RT Journal Article
SR Electronic
T1 Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.09.20082909
DO 10.1101/2020.05.09.20082909
A1 Rivett, Lucy
A1 Sridhar, Sushmita
A1 Sparkes, Dominic
A1 Routledge, Matthew
A1 Jones, Nick K.
A1 Forrest, Sally
A1 Young, Jamie
A1 Pereira-Dias, Joana
A1 Hamilton, William L.
A1 Ferris, Mark
A1 Torok, M. Estee
A1 Meredith, Luke
A1 ,
A1 Curran, Martin
A1 Fuller, Stewart
A1 Chaudhry, Afzal
A1 Shaw, Ashley
A1 Samworth, Richard J.
A1 Bradley, John R.
A1 Dougan, Gordon
A1 Smith, Kenneth G.C.
A1 Lehner, Paul J.
A1 Matheson, Nicholas J.
A1 Wright, Giles
A1 Goodfellow, Ian
A1 Baker, Stephen
A1 Weekes, Michael P.
YR 2020
UL http://medrxiv.org/content/early/2020/05/15/2020.05.09.20082909.abstract
AB Significant differences exist in the availability of healthcare worker (HCW) SARS-CoV-2 testing between countries, and existing programmes focus on screening symptomatic rather than asymptomatic staff. Over a 3-week period (April 2020), 1,032 asymptomatic HCWs were screened for SARS-CoV-2 in a large UK teaching hospital. Symptomatic staff and symptomatic household contacts were additionally tested. Real-time RT-PCR was used to detect viral RNA from a throat+nose self-swab.3% of HCWs in the asymptomatic screening group tested positive for SARS-CoV-2. 17/30 (57%) were truly asymptomatic/pauci-symptomatic. 12/30 (40%) had experienced symptoms compatible with coronavirus disease 2019 (COVID-19) >7 days prior to testing, most self-isolating, returning well. Clusters of HCW infection were discovered on two independent wards. Viral genome sequencing showed that the majority of HCWs had the dominant lineage B·1. Our data demonstrates the utility of comprehensive screening of HCWs with minimal or no symptoms. This approach will be critical for protecting patients and hospital staff.Principal Investigators Stephen Baker, John Bradley, Gordon Dougan, Ian Goodfellow, Ravi Gupta, Paul J. Lehner, Paul A. Lyons, Nicholas J. Matheson, Kenneth G.C. Smith, M. Estee Torok, Mark Toshner, Michael P. WeekesInfectious Diseases Department Nicholas K. Jones, Lucy Rivett, Matthew Routledge, Dominic Sparkes, Ben WarneSARS-CoV-2 testing team Josefin Bartholdson Scott, Claire Cormie, Sally Forrest, Harmeet Gill, Iain Kean, Mailis Maes, Joana Pereira-Dias, Nicola Reynolds, Sushmita Sridhar, Michelle Wantoch, Jamie YoungCOG-UK Cambridge Sequencing Team Sarah Caddy, Laura Caller, Theresa Feltwell, Grant Hall, William Hamilton, Myra Hosmillo, Charlotte Houldcroft, Aminu Jahun, Fahad Khokhar, Luke Meredith, Anna YakovlevaNIHR BioResource Helen Butcher, Daniela Caputo, Debra Clapham-Riley, Helen Dolling, Anita Furlong, Barbara Graves, Emma Le Gresley, Nathalie Kingston, Sofia Papadia, Hannah Stark, Kathleen E. Stirrups, Jennifer WebsterResearch nurses Joanna Calder, Julie Harris, Sarah Hewitt, Jane Kennet, Anne Meadows, Rebecca Rastall, Criona O,Brien, Jo Price, Cherry Publico, Jane Rowlands, Valentina Ruffolo, Hugo TordesillasNIHR Cambridge Clinical Research Facility Karen Brookes, Laura Canna, Isabel Cruz, Katie Dempsey, Anne Elmer, Naidine Escoffery, Stewart Fuller, Heather Jones, Carla Ribeiro, Caroline Saunders, Angela WrightCambridge Cancer Trial Centre Rutendo Nyagumbo, Anne RobertsClinical Research Network Eastern Ashlea Bucke, Simone Hargreaves, Danielle Johnson, Aileen Narcorda, Debbie Read, Christian Sparke, Lucy WarboysAdministrative staff, CUH Kirsty Lagadu, Lenette MactavousCUH NHS Foundation Trust Tim Gould, Tim Raine, Ashley ShawCambridge Cancer Trials Centre Claire Mather, Nicola Ramenatte, Anne-Laure VallierLegal/Ethics Mary KasanickiCUH Improvement and Transformation Team Penelope-Jane Eames, Chris McNicholas, Lisa ThakeClinical Microbiology & Public Health Laboratory (PHE):Neil Bartholomew, Nick Brown, Martin Curran, Surendra Parmar, Hongyi ZhangOccupational Health Ailsa Bowring, Mark Ferris, Geraldine Martell, Natalie Quinnell, Giles Wright, Jo WrightHealth and Safety Helen MurphyDepartment of Medicine Sample Logistics Benjamin J. Dunmore, Ekaterina Legchenko, Stefan Gräf, Christopher Huang, Josh Hodgson, Kelvin Hunter, Jennifer Martin, Federica Mescia, Ciara O’Donnell, Linda Pointon, Joy Shih, Rachel Sutcliffe, Tobias Tilly, Zhen Tong, Carmen Treacy, Jennifer WoodDepartment of Medicine Sample Processing and Acquisition:Laura Bergamaschi, Ariana Betancourt, Georgie Bowyer, Aloka De Sa, Maddie Epping, Andrew Hinch, Oisin Huhn, Isobel Jarvis, Daniel Lewis, Joe Marsden, Simon McCallum, Francescsa Nice, Ommar Omarjee, Marianne Perera, Nika Romashova, Mateusz Strezlecki, Natalia Savoinykh Yarkoni, Lori TurnerEpic team/other computing support Barrie Bailey, Afzal Chaudhry, Rachel Doughton, Chris WorkmanStatistics/modelling Richard J. Samworth, Caroline TrotterCompeting Interest StatementLucy Rivett has nothing to disclose. Sushmita Sridhar has nothing to disclose. Dominic Sparkes has nothing to disclose. Matthew Routledge has nothing to disclose. Nick Jones has nothing to disclose. Sally Forrest has nothing to disclose. Jamie Young has nothing to disclose. Joana Pereira-Dias has nothing to disclose. William Hamilton has nothing to disclose. Mark Ferris has nothing to disclose. M. Estee Torok reports grants from Academy of Medical Sciences and the Health Foundation, non-financial support from National Institute of Health Research, during the conduct of the study; grants from Medical Research Council, grants from Global Challenges Research Fund, personal fees from Wellcome Sanger Institute, personal fees from University of Cambridge, personal fees from Oxford University Press, outside the submitted work. Luke Meredith has nothing to disclose. Neil Bartholomew has nothing to disclose. Surendra Parmar has nothing to disclose. Martin Curran has nothing to disclose. Stewart Fuller has nothing to disclose. Afzal Chaudhry reports grants from Cambridge Biomedical Research Centre at CUHNFT, during the conduct of the study. Ashley Shaw has nothing to disclose. Richard J. Samsworth reports grants from EPSRC fellowship, during the conduct of the study. John Bradley has nothing to disclose. Gordon Dougan reports grants from NIHR, during the conduct of the study.Kenneth G.C. Smith reports grants from Wellcome Trust, during the conduct of the study. Paul J. Lehner reports grants from Wellcome Trust Principal Research Fellowship, grants from Addenbrooke's Charitable Trust, during the conduct of the study. Nicholas J. Matheson reports grants from Medical Research Council (Clinician Scientist Fellowship), grants from NHS Blood and Transfusion, during the conduct of the study. Giles Wright has nothing to disclose. Ian Goodfellow reports grants from Wellcome Trust (Senior Research Fellowships), grants from Wellcome Trust (Collaborative Award), grants from Addenbrooke's Charitable Trust, during the conduct of the study. Stephen Baker reports grants from Wellcome Trust (Senior Research Fellowships), from Addenbrooke's Charitable Trust, during the conduct of the study. Michael P. Weekes reports grants from Wellcome Trust (Senior Research Fellowships), from Addenbrooke's Charitable Trust, during the conduct of the study.Funding StatementThis work was supported by the Wellcome Trust Senior Research Fellowships 108070/Z/15/Z to MPW, 215515/Z/19/Z to SGB and 207498/Z/17/Z to IGG; Collaborative award 206298/B/17/Z to IGG; Principal Research Fellowship 210688/Z/18/Z to PJL; Investigator Award 200871/Z/16/Z to KGCS; Addenbrooke’s Charitable Trust (to MPW, SGB, IGG and PJL); the Medical Research Council (CSF MR/P008801/1 to NJM); NHS Blood and Transfusion (WPA15-02 to NJM); National Institute for Health Research (Cambridge Biomedical Research Centre at CUHNFT), to JRB, MET, AC and GD, Academy of Medical Sciences and the Health Foundation (Clinician Scientist Fellowship to MET), Engineering and Physical Sciences Research Council (EP/P031447/1 and EP/N031938/1 to RS),Cancer Research UK (PRECISION Grand Challenge C38317/A24043 award to JY). Components of this work were supported by the COVID-19 Genomics UK Consortium, (COG-UK), which is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR) and Genome Research Limited, operating as the Wellcome Sanger Institute.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSequencing data have been deposited in GSAID under accession codes EPI_ISL_433989 - EPI_ISL_433992, EPI_ISL_434005, EPI_ISL_433489 - EPI_ISL_433497. The authors confirm all other data supporting the findings of this study are available within the article and its supplementary materials.